35,000
people die of chronic or cirrhotic liver diseases each year in US
13,705
patients were on the waiting list for a liver transplantation in the US in 2016
7,841
liver transplants were reported in the US in 2016

Promethera® Biosciences aims to bring patients life-saving treatments to reduce the need for liver transplantation.

Our passion translates into a commitment to holistically change patients’ lives by not only developing pioneering liver therapies, but also providing high quality education about liver disease and how to prevent it through healthy lifestyle choices.

We are developing cutting-edge cell- and antibody-based therapies for the treatment of liver diseases.

HepaStem is our most advanced cell-based therapy which has the potential to deliver novel treatment options for chronic and acute liver diseases including Acute-on-Chronic Liver Failure (ACLF), fibrosis and Non-Alcoholic SteatoHepatitis (NASH).

A unique set of technological assets, exclusive IP & know-how.

A broad intellectual property portfolio, which includes a proprietary antibody therapy, human organ and cell sourcing and manufacturing capabilities, positions the Promethera® Group as a global leader in regenerative medicine and cell therapy for liver diseases.

Restoring Liver Health

Twitter feed

📢 We are hiring! Meet our team at the ULB Jobdays on February 27th and find out why a job in a biotech company is so exciting! See you there. In the meantime, check out the open positions on our website. #lifesciences #teamwork #biotech #promethera #newjob

Full information on the #DHELIVER trial is now available on http://clinicaltrials.gov. First trial sites are being initiated in Belgium @UZLeuven and Bulgaria with further updates expected in the weeks ahead http://bit.ly/2GkSvzf

Looking forward to presenting at the #biotechshowcase! Come and hear our #CEO John Tchelingerian, meet our team and learn more about Promethera’s work in end stage #liverdiseases such as #ACLF and #NASH on Monday, January 13, at 11:45AM in Franciscan C at the Hilton San Francisco